{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:37:55Z","timestamp":1762317475656,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.eplepsyres.2025.107544","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:45:18Z","timestamp":1741783518000},"page":"107544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Use of oral anti-seizure medication via nasogastric tube to treat IV-diazepam resistant status epilepticus in a setting with limited resources: An observational study"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9704-7141","authenticated-orcid":false,"given":"Fitri","family":"Octaviana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian Ridski","family":"Harsono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winnugroho","family":"Wiratman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luh Ari","family":"Indrawati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astri","family":"Budikayanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2025.107544_bib1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.addr.2012.01.017","article-title":"Current oral and non-oral routes of antiepileptic drug delivery","volume":"64","author":"Anderson","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107544_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaneurol.2015.0188","article-title":"Trends in status epilepticus\u2014related hospitalizations and mortality redefined in US practice over time","volume":"72","author":"Betjemann","year":"2015","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107544_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40265-016-0672-2","article-title":"Topiramate in the treatment of generalized convulsive status epilepticus in adults: a systematic review with individual patient data analysis","volume":"77","author":"Brigo","year":"2017","journal-title":"Drugs"},{"issue":"10231","key":"10.1016\/j.eplepsyres.2025.107544_bib4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2025.107544_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1528-1157.1999.tb02070.x","article-title":"Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes","volume":"40","author":"DeLorenzo","year":"2005","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.eplepsyres.2025.107544_bib6","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/epi.16382","article-title":"Treatment of refractory and superrefractory status epilepticus with topiramate: a cohort study of 106 patients and a review of the literature","volume":"60","author":"Fechner","year":"2019","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.eplepsyres.2025.107544_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258602","article-title":"De-novo non-convulsive status epilepticus in adult medical inpatients without known epilepsy: analysis of mortality related factors and literature review","volume":"16","author":"Garcia-Villafranca","year":"2021","journal-title":"PloSOne"},{"key":"10.1016\/j.eplepsyres.2025.107544_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000363344","article-title":"Oral loading of sodium valproate compared to intravenous loading and oral maintenance in acutely manic bipolar patients","volume":"70","author":"Ghaleiha","year":"2014","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107544_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107544_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2025.107544_bib11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","article-title":"Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability","volume":"36","author":"Kienitz","year":"2022","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.eplepsyres.2025.107544_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1528-1167.2005.00409.x","article-title":"Mortality after a first episode of status epilepticus in the United States and Europe","volume":"46","author":"Logroscino","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107544_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.seizure.2016.03.003","article-title":"Assessing the value of topiramate in refractory status epilepticus","volume":"38","author":"Mad\u017ear","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2025.107544_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0042-1758483","article-title":"Hemodynamic effects an QTc changes with intravenous phenytoin and fosphenytoin during propofol and sevoflurane anesthesia","volume":"10","author":"Maremanda","year":"2023","journal-title":"J. Neuroanaesth. Crit. Care"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107544_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.14581\/jer.15003","article-title":"Evaluation of short-term mortality of status epilepticus and its risk factors","volume":"5","author":"Moghaddasi","year":"2015","journal-title":"J. Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2025.107544_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.seizure.2005.12.003","article-title":"The use of levetiracetam in refractory status epilepticus","volume":"15","author":"Patel","year":"2006","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.eplepsyres.2025.107544_bib17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2025.107544_bib18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2025.107544_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s13311-018-0640-5","article-title":"Treatment of refractory and super-refractory status epilepticus","volume":"15","author":"Rai","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.eplepsyres.2025.107544_bib20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586.x","article-title":"Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study","volume":"47","author":"Ramael","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107544_bib21","first-page":"117","article-title":"Standards of care for non-convulsive status epilepticus: Belgian consensus recommendations","volume":"106","author":"Rijckevorsel","year":"2006","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107544_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/epi.14602","article-title":"High long-term mortality after incident status epilepticus in adults: results from a population-based study","volume":"60","author":"Rodin","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107544_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/epi.14515","article-title":"Long-term outcomes of status epilepticus: a critical assessment","volume":"59","author":"Sculier","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107544_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107544_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jppr.1787","article-title":"Significant predictors for topiramate pharmacokinetics: a systematic review of population pharmacokinetic studies","volume":"52","author":"Tippayachai","year":"2022","journal-title":"J. Pharm. Pract. Res."},{"key":"10.1016\/j.eplepsyres.2025.107544_bib26","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107544_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2023.1081757","article-title":"Mortality, and life expectancy in Epilepsy and Status epilepticus-current trends and future aspects","volume":"3","author":"Trinka","year":"2023","journal-title":"Front Epidemiol."},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107544_bib28","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/ene.15441","article-title":"Valproate in status epilepticus: Correlation between loading dose, serum levels, and clinical response","volume":"29","author":"Vijiala","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107544_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13380","article-title":"Efficacy and safety of levetiracetam versus valproate in patients with established status epilepticus: a systematic review and meta-analysis","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.eplepsyres.2025.107544_bib30","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0883073808331351","article-title":"Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study","volume":"24","author":"Wheless","year":"2009","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107544_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ccc.2012.11.007","article-title":"Pediatric intensive care treatment of uncontrolled status epilepticus","volume":"29","author":"Wilkes","year":"2013","journal-title":"Crit. Care Clin."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107544_bib32","first-page":"192","article-title":"Clinical pharmacology and pharmacokinetics of levetiracetam","volume":"4","author":"Wright","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107544_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2013.00192","article-title":"Clinical pharmacology and pharmacokinetics of levetiracetam","volume":"4","author":"Wright","year":"2013","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.eplepsyres.2025.107544_bib34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.58.7.1070","article-title":"Incidence and mortality of generalized convulsive status epilepticus in California","volume":"58","author":"Wu","year":"2002","journal-title":"Neurology"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:34:19Z","timestamp":1762317259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"alternative-id":["S0920121125000452"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107544","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of oral anti-seizure medication via nasogastric tube to treat IV-diazepam resistant status epilepticus in a setting with limited resources: An observational study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107544"}}